CytoMed Therapeutics Ltd
GDTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873093
In the last 90 days, CytoMed Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 3 institutions reported holding it in 13F filings for Q2 2026, worth $12.2K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by CytoMed Therapeutics Ltd insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 1 filing
- 1 insider, $300.0K in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$300.0K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for CytoMed Therapeutics Ltd, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Choo Chee Kong | Director, 10% Owner | 630,324 | Jul 24, 2026 | 2 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 24, 2026 (view filing)9:01 PM ET | Jul 14-20 | 10 days | Choo Chee KongDirector, 10% Owner | PPurchaseORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED | +200.0K | $1.50 | +$300.0K | +46.5%630.3K after | Amended2 lots |
| Jun 15, 2026 (view filing) | May 13 | 33 daysLate | Choo Chee KongDirector, 10% Owner | PPurchaseOrdinary Shares, no par value per share | +112.0K | $1.15 | +$128.8K | +35.2%430.3K after |